EDIT Shares Outstanding History



Below is a table of the EDIT shares outstanding history going back to 2/3/2016:

Date EDIT Shares Outstanding
2/3/201635.70M
3/18/201636.61M
5/6/201636.61M
8/1/201636.61M
11/1/201636.66M
2/1/201736.68M
5/5/201741.35M
8/7/201741.63M
10/31/201742.12M
2/28/201846.88M
4/27/201847.20M
8/3/201847.68M
10/31/201847.81M
2/8/201949.09M
5/3/201949.22M
8/1/201949.52M
7/31/2019617.27M
11/1/201951.30M
2/14/202054.88M
5/1/202055.00M
7/31/202062.27M
10/30/202062.33M
2/14/202167.36M
4/30/202167.83M
7/30/202168.26M
11/5/202168.40M
2/14/202268.52M
4/29/202268.64M
7/29/202268.74M
10/28/202268.76M
2/17/202368.97M
4/28/202369.00M
7/28/202381.63M
10/27/202381.67M

Also see: EDIT Market Cap History
EDIT YTD Return
EDIT Historical Shares Outstanding:
+11.30% CAGR
EDIT Historical Shares Outstanding: +11.30% CAGR

Mouse over chart for data details
2/3/2016 ...10/27/2023
Editas Medicine is a clinical stage genome editing company focused on developing genomic medicines to treat a range of serious diseases. Co. has developed a proprietary genome editing platform based on clustered, regularly interspaced, short palindromic repeats technology and it continues to expand its capabilities. Co. is developing in vivo gene editing medicines, in which the medicine is injected or infused into the patient to edit the cells inside their body, ex vivo gene-edited cell medicines, in which cells collected from a patient are edited with Co.'s technology and then administered back to that same patient, and cellular therapy medicines. We show 34 historical shares outstanding datapoints in our coverage of EDIT's shares outstanding history.

Understanding the changing numbers of EDIT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EDIT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EDIT by allowing them to research EDIT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree EDIT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Editas Medicine (EDIT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

EGLT Shares Outstanding History
EGRX Shares Outstanding History
EHAB Shares Outstanding History
EHC Shares Outstanding History
EIDX Shares Outstanding History
EIGR Shares Outstanding History
EKSO Shares Outstanding History
ELAN Shares Outstanding History
ELDN Shares Outstanding History
ELEV Shares Outstanding History
More Healthcare companies »

 

EDIT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.